Confirmed Supporters

Confirmed Sponsors

STI & HIV 2019 would like to thank the following companies for their generous support:


Confirmed Exhibitors


Abbott Molecular Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines. Our 103,000 colleagues serve people in more than 160 countries. (


BD Diagnostic Systems 
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD helps customers enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. (


bioLytical Laboratories Inc.
bioLytical Laboratories based in Richmond, BC, is a privately-owned Canadian company focused on the research, development, and commercialization of rapid, point-of-care in-vitro medical diagnostics using its proprietary INSTI® technology platform. The INSTI product line provides highly accurate test results in 60 seconds or less with over 99% accuracy. (


Center for Disease Detection
Center for Disease Detection (CDD) is one of the nation’s leading laboratories, providing testing to customers in all 50 states as well as internationally. Founded in 1990, CDD services federal, state and local government agencies, STD clinics, and organizations dedicated to sexual health. (


Cepheid is a leading on-demand molecular diagnostics company that is dedicated to improving healthcare by developing fully-integrated systems and accurate yet easy-to-use molecular tests. The company is focusing on applications where rapid and actionable test results are needed most, in fields such as critical and healthcare-associated infections, sexual health, genetic diseases, virology and cancer. (


Chembio Diagnostic Systems. Inc. 
Chembio Diagnostic Systems, Inc. is a leading point-of-care diagnostics company focused on detecting and diagnosing infectious diseases. The company’s patented DPP® technology platform, which uses a small drop of blood from the fingertip, provides high-quality, cost-effective results in 15-20 minutes. The novel DPP® technology offers broad market applications beyond infectious disease. (


With a rightful reputation for innovation, COPAN is the world leading manufacturer of collection and transport systems. In like manner, COPAN’s collaborative approach to pre-analytics has resulted in the development of FLOQSwabs®, ESwab®, UTM® and modular laboratory automation, WASP® and WASPLab®. (


EUROIMMUN AG a PerkinElmer Company
EUROIMMUN is an international provider of medical laboratory products with a growing molecular genetic diagnostics portfolio. The company’s EUROArray platform provides multiplex detection of sexually transmitted pathogens, HPV or dermatophytes. Real-time PCR tests for Zika virus and HSV-1/2 and microarrays for genetic risk determination in many different diseases complete the portfolio. (


A global champion of women’s health, Hologic is an innovative medical technology company that enables healthier lives everywhere, every day through The Science of Sure: Clinical superiority that delivers life-changing diagnostic, detection, surgical and medical aesthetic products rooted in science and driven by technology. (


ImmunoPrecise Antibodies 
ImmunoPrecise is a full-service, therapeutic antibody discovery company focused on the next generation of antibody solutions; delivering the most therapeutically-relevant antibodies, in a shorter period of time, with the highest probability of succeeding to clinical trials. Our comprehensive collection of discovery platforms include transgenic animals, B-cell selection, phage display, and hybridoma development. Our extensive experience with multiple transgenic platforms provides clients access to reliable and effective therapeutic human antibody selection, available through all ImmunoPrecise’s discovery platforms. (




SD Biosensor 
SD Biosensor is an IVD manufacturer based in Korea. It offers a large range of portfolio such as rapid diagnostic, glucometer, ELISA test, immunochromatography and fluorescence analyzer etc. Currently SD Biosensor is developing new POC MDx platform which makes SD Biosensor a total diagnostic provider from screening to confirmatory test. (


Seegene Inc.
Seegene is the world’s leading developer of multiplex molecular technologies and diagnostic products. Seegene’s innovative proprietary technologies enable the simultaneous detection, differentiation and quantification of multiple targets with high sensitivity, specificity and reproducibility and perform on unique streamlined automation solution. Seegene’s products, in particularly for sexually transmitted infections, provide accurate and comprehensive information on infected STI, BV and HPV pathogens. (


SpeeDx Pty. Ltd.
SpeeDx is a privately owned company founded in 2009. Based in Sydney with subsidiary offices in London and the US, SpeeDx specialises in innovative multiplex real-time polymerase chain reaction (qPCR) solutions for clinical diagnostics. SpeeDx has a portfolio of CE-IVD multiplex qPCR kits for detection of infectious disease pathogens and antimicrobial resistance markers. Resistance-guided therapy improves patient outcomes by empowering practitioners to make informed clinical decisions. (


STEMCELL Technologies 
STEMCELL Technologies provides cell isolation products for studying HIV and other infectious diseases. Our cell separation technologies, EasySep™, RosetteSep™ and SepMate™ facilitate rapid human blood processing. SepMate™ registered as an IVD device, isolates PBMC in just 15 minutes. RoboSep™ fully automates EasySep™ cell isolation, minimizing sample handling and eliminating cross-contamination. (


Stichting World STI & HIV Congress 2021 
Herewith we would like to welcome you to the 24th STI & HIV World Congress 2021, to be held from 18 until 21 July 2021 in Amsterdam, The Netherlands. The organisers have chosen “Urban Diversity and Sexual Health” as the conference theme. It is no coincidence that with a simple reshuffle of words an alternative theme “Sexual Diversity and Urban Health” would be just as applicable. Amsterdam is a very popular destination and very easy to travel to. (


Youth against AIDS 
In a world impacted by major technological and social disruptions “Youth against AIDS” goes new ways to face the HIV & STI epidemic among young generations. “Youth against AIDS” is convinced that great innovations are necessary to meet the needs of the young target group, and to become a close partner in young peoples lifes. “Youth against AIDS” builds networks to create innovation in prevention and to create a major change in young peoples individual health management. (

Other Supporters



Congress Newsletter


Subscribe to the Newsletter to receive important information about the upcoming congress.